• Home Blog Tag Familial chylomicronemia syndrome

Familial Chylomicronemia Syndrome

Jan 29, 2024

Atherosclerotic Cardiovascular Disease (ASCVD) Treatment Approaches: Beyond Statins

Mar 27, 2023

Potential of APOCIII Inhibitors for Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Treatment

Mar 21, 2023

AbbVie Announces Results of Study Evaluating SKYRIZI; FDA Fast Track Designation to Arrowhead’s ARO-APOC3; FDA Approves Dabrafenib Plus Trametinib for BRAF V600E–Mutated Low-Grade Glioma; FDA Grants ODD to Novel BRAF Inhibitor for Brain/CNS Malignancies; EP0042 Wins FDA Orphan Drug Status; Karuna Therapeutics Announces Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia

Jul 24, 2020

Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

Newsletter/Whitepaper